Insulin pumps are still debatable for type 1 diabetes

BMJ 2002; 325 doi: 10.1136/bmj.325.7354.46 (Published 6 July 2002)
Cite this as: BMJ 2002;325:46.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. J Hans DeVries, endocrinologist (hans.devries@vumc.nl),
  2. Robert J Heine, professor of diabetology
  1. VU Medical Centre, Diabetes Centre, PO Box 7057, 1007 MB, Amsterdam, Netherlands

    EDITOR—We have three comments about Pickup et al's meta-analysis comparing insulin infusion with injection, which may cast a different light on their main conclusion.1

    Firstly, the results of the largest study in the meta-analysis, the so called Dusseldorf study, needs careful interpretation. The authors have estimated this study to show a positive result for continuous subcutaneous insulin infusion, with an advantage in percentage of glycated haemoglobin of 0.68%. This figure will be an estimation made from a …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL